Symbiotec Pharmalab share news, announcements
NSE: SYMBIOTECBSE: 544889Pharmaceuticals & Biotechnology
Symbiotec Pharmalab Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2026 · Issue price ₹988
Last close ₹1,246.30down ₹3.90 (0.31%)BSE ₹1,245.15
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,250.20.
30 Oct: open ₹1,250.00, high ₹1,267.50, low ₹1,217.00
Range of traded prices from listing on 1 Sep 2026 to 30 Oct 2026
₹934.20Low, 1 Sep 2026₹1,309.90High, 16 Oct 2026
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹8,008 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No balance sheet
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Sep 2026
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,70,33435.1% delivered
Symbiotec Pharmalab analyst meets
3 filed, newest first.
Oct 2026
28 Oct · Analysts
Sep 2026